Change in Colony Morphology of Candida lusitaniae in Association with Development of Amphotericin B Resistance
AUTOR(ES)
McClenny, Nancy B.
FONTE
American Society for Microbiology
RESUMO
It is not uncommon to see amphotericin B treatment failure in patients with systemic infection caused by Candida lusitaniae. We report a patient with stage IV ovarian carcinoma and C. lusitaniae sepsis whose treatment with amphotericin B failed. The initial blood isolate was susceptible to amphotericin B in vitro; however, the MIC for a blood isolate recovered 7 weeks after treatment began showed a fourfold increase. Direct subculture of two positive blood samples obtained within a week of the patient's death showed the coexistence of two distinct colony color variants on CHROMagar Candida (CAC). One variant was susceptible to amphotericin B, and one was resistant. These results emphasize the importance of repeat amphotericin B susceptibility testing for patients with persistent C. lusitaniae infection. The presence of colony variants on CAC may signal the emergence of amphotericin B resistance in C. lusitaniae and should be investigated.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=127144Documentos Relacionados
- Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human
- Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae
- Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance.
- High-Frequency, In Vitro Reversible Switching of Candida lusitaniae Clinical Isolates from Amphotericin B Susceptibility to Resistance
- Fatal septicemia due to amphotericin B-resistant Candida lusitaniae.
